1. Introduction {#sec1-tropicalmed-03-00071}
===============

Dengue viruses (DENVs) are single-stranded positive-sense RNA viruses globally responsible for an estimated 300 million infections annually \[[@B1-tropicalmed-03-00071]\]. The clinical disease spectrum associated with DENV infection ranges from mild febrile illness through to potentially fatal manifestations, characterized by plasma leakage and shock \[[@B2-tropicalmed-03-00071]\]. There are four DENV serotypes (denoted DENV-1, -2, -3, and -4), which are predominately transmitted between humans via *Aedes aegypti*, although *Aedes albopictus* can be a vector in some instances \[[@B3-tropicalmed-03-00071]\].

Due to the lack of a highly effective vaccine, the primary control strategy for dengue relies on mosquito suppression. This generally involves elimination of water-holding containers that support larval development, and/or application of insecticides targeting larvae and adults. Unfortunately, the effectiveness of control strategies targeting *Ae. aegypti* and *Ae. albopictus* is compromised by the close association between these species and human habitation, which provides numerous containers for larval development, preferred human blood meals, and intradomiciliary feeding and resting sites. Furthermore, incidence of insecticide resistance in populations of *Ae. aegypti* and *Ae. albopictus* is increasing, further impacting the efficacy of mosquito control programs \[[@B4-tropicalmed-03-00071]\].

Whilst dengue imposes its greatest burden on developing countries, outbreaks in Key West (Florida) and northern Australia illustrate the vulnerability of any *Ae. aegypti*-infested region to local DENV transmission \[[@B5-tropicalmed-03-00071],[@B6-tropicalmed-03-00071]\]. Australia has a history of dengue epidemics that stretches back to the late 1800s, although there was a significant increase in the frequency of outbreaks in the last 25 years. Due to the constant threat of DENVs, Australian scientists greatly contributed to the understanding of virus transmission cycles, and developed or refined strategies for *Ae. aegypti* surveillance and control that show considerable promise for DENV control in nations where these viruses exact their greatest toll. This paper revisits early Australian experiments conducted to incriminate *Ae. aegypti* as a DENV vector, then fast forwards approximately 100 years to examine recent advances in our knowledge of *Ae. aegypti* biology and DENV control that Australian scientists performed a lead role in developing.

2. Dengue in Australia {#sec2-tropicalmed-03-00071}
======================

Although the exact timing of introduction is unknown, it is estimated that *Ae. aegypti* was first introduced into Australia in the mid-to-late 19th century \[[@B7-tropicalmed-03-00071]\]. Disease attributed to infection with DENVs was first reported in Australia in the 1870s, and the first widespread outbreak occurred in Queensland in 1897, which included the first formal description of dengue hemorrhagic fever ([Figure 1](#tropicalmed-03-00071-f001){ref-type="fig"}) \[[@B8-tropicalmed-03-00071]\]. This outbreak was followed by another in 1905, which afflicted an estimated 75% of the then population of the state capital, Brisbane, of 125,672, resulting in 94 deaths \[[@B9-tropicalmed-03-00071]\]. Other significant outbreaks occurred in 1916, 1925--1926, and 1942--1943, with each affecting a wide geographical area in northern Australia, and infecting a high proportion of residents in some towns (reviewed in \[[@B10-tropicalmed-03-00071]\]). After a period of little activity, an outbreak of dengue occurred in northern Queensland in 1954--1955, affecting an estimated 15,000 people out of 40,000 in Townsville alone \[[@B11-tropicalmed-03-00071]\].

The latter epidemic was the last to occur in Australia for 26 years. During this time, the geographical distribution of *Ae. aegypti* in Australia contracted considerably. A number of reasons for this range contraction were proposed, including replacement of rainwater tanks by reticulated water, focused public health campaigns to eliminate larval habitats, general improvements in sanitation, and the introduction of household insecticides \[[@B12-tropicalmed-03-00071],[@B13-tropicalmed-03-00071]\]. The current distribution of *Ae. aegypti* in Australia is restricted to Queensland \[[@B14-tropicalmed-03-00071]\], with the closest record to Brisbane being the township of Goomeri, approximately 160 km northwest of the city \[[@B15-tropicalmed-03-00071]\].

Between 1981 and 1983, a widespread outbreak of DENV-1 involving 458 confirmed cases occurred in north Queensland, signaling the return of epidemic dengue to Australia \[[@B16-tropicalmed-03-00071]\]. Local transmission was not recorded for almost a decade, before sporadic locally-acquired cases occurred in 1990--1991 \[[@B17-tropicalmed-03-00071],[@B18-tropicalmed-03-00071]\]. In 1992--1993, outbreaks primarily centered in Townsville and Charters Towers resulted in over 900 reported cases, although retrospective serological studies suggested the number of cases was considerably higher \[[@B19-tropicalmed-03-00071],[@B20-tropicalmed-03-00071],[@B21-tropicalmed-03-00071]\]. A small cluster of DENV-2 cases was reported from a Cairns suburb in 1995 \[[@B22-tropicalmed-03-00071]\]. From that point, a trend to annual outbreaks of dengue occurred in north Queensland, starting with an outbreak of DENV-2 in the Torres Strait in 1996--1997, which was introduced by a resident who had acquired the infection in Papua New Guinea \[[@B23-tropicalmed-03-00071],[@B24-tropicalmed-03-00071]\].

There is no evidence that DENVs are endemic in Australia; rather, outbreaks (defined as one or more locally acquired cases) are initiated by travellers who acquire the infection overseas. The country where the index case acquired their infection is often not conclusively established. However, nucleotide sequencing and phylogenetic analyses of DENVs responsible for 73 outbreaks reported between 1990 and 2017 suggest that the majority originate from the Asia-Pacific region, with viruses from Indonesia accounting for the highest number (23%) of outbreaks, followed by Papua New Guinea (21%) \[[@B28-tropicalmed-03-00071]\]. Outbreaks can involve anywhere from \<10 cases to 100s of cases, with intensive vector control activities \[[@B29-tropicalmed-03-00071]\] likely restricting their duration and severity. However, these activities can be overwhelmed by delayed notification of cases (particularly the imported index case \[[@B30-tropicalmed-03-00071]\]), weather conditions that dramatically increase mosquito populations, or the circulation of more pathogenic strains of virus. A perfect storm of these factors contributed to an outbreak of DENV-3 in Cairns in 2008--2009 \[[@B6-tropicalmed-03-00071]\]. Nine hundred and thirty-one cases were reported, making it the largest outbreak recorded in Australia for over 50 years.

3. Incrimination of *Ae. aegypti* as a Vector of Dengue Viruses {#sec3-tropicalmed-03-00071}
===============================================================

The seminal experiments conducted by Major Walter Reed and the Yellow Fever Commission in 1900, and work on dengue in Syria by Graham \[[@B31-tropicalmed-03-00071]\], inspired Bancroft \[[@B32-tropicalmed-03-00071]\] to test the hypothesis that the dengue virus was transmitted by mosquitoes to humans. In experiments conducted in Brisbane, locally abundant *Ae. aegypti* (then referred to as *Stegomyia fasciata* \[[@B33-tropicalmed-03-00071]\]) were allowed to feed on patients diagnosed with dengue. After a period of at least 10 days, these mosquitoes were then allowed to bite volunteers, who, in some instances, developed disease typical of dengue. Unfortunately, Brisbane was experiencing a large dengue epidemic at the time, so it was difficult to confirm whether these patients acquired their infection during the experiments or whether infection was naturally contracted. Nonetheless, these experiments were highly suggestive of a role of *Ae. aegypti* in the transmission of DENVs.

To remove any conjecture that the volunteers from Bancroft's work were not infected experimentally, Cleland et al. \[[@B25-tropicalmed-03-00071],[@B26-tropicalmed-03-00071],[@B27-tropicalmed-03-00071]\] conducted similar experiments in a location free from active DENV transmission. Mosquitoes collected whilst biting infected patients during a DENV outbreak in several towns in northern New South Wales were shipped to Sydney, where there was no evidence of active transmission. These mosquitoes were allowed to feed on volunteers, who were then monitored for signs of dengue disease. The first series of experiments were deemed unsuccessful, reportedly due to the high mortality experienced during transport of the mosquitoes. During the second set of experiments, four of nine subjects developed disease commensurate with DENV infection, and were deemed to be infected by bites from *Ae. aegypti*. On the other hand, there was no evidence of DENV being transmitted by *Culex fatigans* (now known as *Cx. quinquefasciatus*), another common mosquito species that was also present in the mosquito collections.

The authors concluded that, based on their experiments and those of Bancroft \[[@B29-tropicalmed-03-00071]\], *Ae. aegypti* was the most likely vector of DENV in Australia. They also suggested that the geographical distribution of this species coincided with the limits of dengue transmission in northern Australia. In contrast, *Cx. quinquefasciatus* is widely distributed throughout Australia, including regions where local transmission was never reported. If this species was indeed a vector, they hypothesized that local DENV transmission would have occurred where this species was abundant, and where numerous imported cases of dengue were reported. The work of Cleland et al. \[[@B25-tropicalmed-03-00071],[@B26-tropicalmed-03-00071],[@B27-tropicalmed-03-00071]\] incriminating *Ae. aegypti* and discounting *Cx. quinquefasciatus* as DENV vectors was subsequently confirmed by Siler et al. \[[@B34-tropicalmed-03-00071]\] in experiments in Manila, Philippines, in the mid-1920s. Clearly, the pioneering work conducted in Australia in the first decades of the 20th century paved the way for over 100 years of research on *Ae. aegypti*, and formulation of strategies for its control.

4. Development of Novel Surveillance and Control Strategies Targeting *Ae. aegypti* {#sec4-tropicalmed-03-00071}
===================================================================================

4.1. Surveillance of Ae. aegypti Populations {#sec4dot1-tropicalmed-03-00071}
--------------------------------------------

A number of indices are traditionally used to define the level of *Ae. aegypti* infestation and its associated risk for DENV transmission \[[@B35-tropicalmed-03-00071],[@B36-tropicalmed-03-00071]\]. These indices provide a relative estimate of the number of containers positive for *Ae. aegypti* larvae or pupae, with the house, container, and Breteau indices most commonly used. However, the accuracy of these indices is compromised by several factors, most notably the heterogeneous distribution of *Ae. aegypti* in the urban environment, varying container size, utilization of cryptic larval habitats, and inspectors being unable to access all premises in a survey area. Critically, there is little correlation between larval indices and adult densities, and the associated dengue incidence \[[@B35-tropicalmed-03-00071]\].

A comprehensive examination of these larval indices, and the relative contribution of cryptic larval habitats, was conducted in north Queensland by researchers from the Queensland Institute of Medical Research (QIMR) in the 1980s and 1990s. Importantly, they demonstrated that a relatively small number (\<10%) of houses accounted for a high proportion (≈50%) of positive containers \[[@B37-tropicalmed-03-00071]\], and designated these highly productive houses as key premises. Similarly, key containers, such as rainwater tanks, wells, and tires, were shown to contribute greatly to *Ae. aegypti* productivity. Other studies revealed that not only were subterranean sites, such as wells, service pits, sump pits, abandoned mine shafts, and drains, highly productive larval habitats in some locations, but they were also linked to DENV exposure, and provided a refuge for *Ae. aegypti* during dry weather conditions \[[@B38-tropicalmed-03-00071],[@B39-tropicalmed-03-00071]\]. Conversely, Montgomery and Ritchie \[[@B40-tropicalmed-03-00071]\] demonstrated that roof gutters could also be highly productive larval habitats. Overall, these studies suggest that during DENV outbreaks, limited resources could be utilized best by targeting key containers and key premises, whilst the contribution of subterranean or elevated sites to productivity should not be underestimated.

Given the issues with immature indices, adult sampling became the recommended paradigm for assessing *Ae. aegypti* populations and subsequent DENV transmission risk \[[@B35-tropicalmed-03-00071],[@B36-tropicalmed-03-00071]\]. Sticky ovitraps were developed and deployed in the 2000s for surveillance of adult *Ae. aegypti* in the Cairns region of north Queensland, providing a tool to assess the relative abundance of gravid *Ae. aegypti* during routine monitoring, as well as complementing lethal ovitrap deployments used for dengue control, and for providing mosquitoes for virus detection \[[@B41-tropicalmed-03-00071],[@B42-tropicalmed-03-00071]\]. However, operational issues with adhesives compromised the deployment of sticky ovitraps in some locations \[[@B6-tropicalmed-03-00071]\]. Whilst it was developed in Germany, some of the early assessment of the efficacy of the Biogents Sentinel (BGS) trap was conducted in Cairns \[[@B43-tropicalmed-03-00071],[@B44-tropicalmed-03-00071]\], and these traps are now used routinely for surveillance of *Ae. aegypti* populations both in Australia and globally \[[@B6-tropicalmed-03-00071],[@B45-tropicalmed-03-00071],[@B46-tropicalmed-03-00071]\]. Although BGS traps are effective for collecting all physiological stages of both sexes of *Ae. aegypti* \[[@B43-tropicalmed-03-00071]\], they are relatively expensive and require a source of electricity. The Gravid *Aedes* Trap (GAT) was developed as an alternative to sticky ovitraps and BGS traps, and represents a relatively inexpensive trap for monitoring adult *Ae. aegypti* \[[@B47-tropicalmed-03-00071],[@B48-tropicalmed-03-00071]\], including males that can be attracted by sound lures broadcasting female flight tones \[[@B49-tropicalmed-03-00071]\].

Given the former presence of *Ae. aegypti* in Brisbane and the constant threat of *Ae. albopictus* being introduced, considerable resources are required to confirm the continued absence of these species in southeast Queensland. Deployment of adult traps in extensive arrays over a large spatial scale during presence--absence surveys can be expensive and logistically challenging. Ovitraps provide an inexpensive and sensitive trap alternative. However, the time and laboratory resources required to rear and identify larvae compromises their efficacy. To expedite presence--absence surveys over a large geographical area, Montgomery et al. \[[@B15-tropicalmed-03-00071]\], developed the Rapid Surveillance for Vector Presence (RSVP), which integrates ovitraps, egg quantification, and molecular identification of newly-hatched first instar larvae. The molecular assays developed for RSVP can detect a single first instar *Ae. aegypti* larva in a pool of 5000 non-target first instar larvae, so eggs from multiple ovitraps can be pooled for each diagnostic test, thus reducing processing time.The RSVP is now implemented operationally by local governments in southeast Queensland, and the utility of citizen science for increasing the number of ovitrap collections is currently being evaluated (<https://metrosouth.health.qld.gov.au/zika-mozzie-seeker>; accessed on 30 May 2018). For this pilot project, residents deploy ovitraps for a two-week period before posting ovistrips to a central diagnostic facility for analysis.

4.2. Evolution of Insecticide-Based Methodologies {#sec4dot2-tropicalmed-03-00071}
-------------------------------------------------

In the early 1990s, control of *Ae. aegypti* in north Queensland by health authorities primarily relied on source reduction and treatment of larval habitats with the organophosphate insecticide, temephos, as well as occasional supplementation with outdoor ultra-low volume (ULV) application of pyrethroid and organophosphate insecticides \[[@B50-tropicalmed-03-00071]\]. Indeed, these strategies still form the mainstay of DENV control in many parts of the world \[[@B51-tropicalmed-03-00071]\]. In 1995, the insect growth regulator *s*-methoprene was first introduced into dengue control operations in north Queensland during a small outbreak of DENV-2 in Cairns (\[[@B22-tropicalmed-03-00071]\], S. Ritchie, personal communication). When compared with other insecticides, *s*-methoprene has limited non-target effects, pellet and briquette formulations provide residual control, and there is little evidence of resistance in target mosquito species \[[@B52-tropicalmed-03-00071]\].

During a widespread outbreak of DENV-2 in the Torres Strait in 1997--1998 \[[@B24-tropicalmed-03-00071]\], it soon became evident that source reduction and treatment of larval containers alone was not sufficient to stop transmission. It was decided that adult female *Ae. aegypti* needed to be targeted indoors, where it was biting and resting. Thus, a team was dispatched to Erub Island to apply the residual pyrethroid insecticide, deltamethrin, within houses using a portable ULV space sprayer. This method was then used on several other islands, and possibly limited transmission on islands where this indoor fogging was applied. Similar application of insecticides, this time with the over-the-counter residual pyrethroid, cypermethrin, was used to supplement larval control strategies when transmission expanded to Cairns \[[@B24-tropicalmed-03-00071]\].

Between 1997 and 1999, an outbreak of DENV-3 centered in Cairns caused almost 500 cases, with 20% of notified cases hospitalized \[[@B53-tropicalmed-03-00071]\]. It was during this outbreak that indoor surface spraying using the residual pyrethroids, deltamethrin and lambda-cyhalothrin, was integrated into emergency control strategies to interrupt transmission. This targeted indoor residual spraying (TIRS; \[[@B54-tropicalmed-03-00071]\]) consisted of spraying indoor resting sites of *Ae. aegypti*, such as under tables, inside cupboards, or any other dark location, with aqueous formulations using pneumatic sprayers; control generally lasted four to eight weeks. Another weapon was added to the dengue control arsenal in north Queensland in 2003, when intensive lethal oviposition trap (ovitrap) arrays, similar in design to those trialed in Brazil and Thailand \[[@B55-tropicalmed-03-00071],[@B56-tropicalmed-03-00071]\], were operationally deployed as part of a response to a DENV-2 outbreak \[[@B57-tropicalmed-03-00071]\].

Recent analyses conducted by Vazquez-Prokopec et al. \[[@B54-tropicalmed-03-00071],[@B58-tropicalmed-03-00071]\] on outbreaks of DENV-2 and DENV-3 in Cairns in 2003 and 2008--2009, respectively, revealed that TIRS integrated with contact tracing of notified dengue cases and larval control can lead to a significant decrease in the probability of future DENV transmission. Whilst this strategy was undoubtedly successful in north Queensland for focal outbreaks, it is very resource- and labor-intensive. Thus, it may be difficult to implement TIRS during intense epidemics in regions with poorly-developed public health systems. Instead, Vazquez-Prokopec et al. \[[@B54-tropicalmed-03-00071]\] suggested that prophylactic TIRS, coupled with source reduction, could be implemented prior to the transmission season, and focused on at-risk neighborhoods, such as those with a history of DENV outbreaks.

Of significance, it was suggested that the current pyrethroid susceptibility of Australian *Ae. aegypti* populations is due to the use of strategies that employ different modes of action. Larvae are controlled using the insect growth regulator, *s*-methoprene, while synthetic pyrethroids are used to kill adults using TIRS and lethal ovitraps \[[@B59-tropicalmed-03-00071]\]. This contrasts with *Ae. aegypti* populations from other countries, where widespread indiscriminate application of adulticides (e.g., outdoor ULV space spraying) and larvicides with the same mode of action, led to high levels of pyrethroid resistance \[[@B4-tropicalmed-03-00071]\].

4.3. Predatory Copepods as a Key Component of a Community-Based Dengue Control Strategy in Vietnam {#sec4dot3-tropicalmed-03-00071}
--------------------------------------------------------------------------------------------------

The considerable burden of dengue in Vietnam prompted the formulation of a community-based strategy to reduce populations of *Ae. aegypti*. Australian scientists provided expert technical advice to their counterparts in Vietnam, whilst considerable funding was provided by the Australian Government and United Kingdom's foreign aid programs. The strategy consisted of 4 main elements: (a) community engagement, with support provided by various levels of government; (b) prioritization of control resources based on mosquito productivity from key containers; (c) deployment of predatory copepods of the genus *Mesocyclops* to consume *Ae. aegypti* larvae in water storage vessels; and (d) community participation in various elements of the control program \[[@B60-tropicalmed-03-00071]\].

This strategy was a departure from government-administered programs which historically struggled to provide long-term control of *Ae. aegypti*. Instead, much of the responsibility was transferred to the communities, whilst containers that produced the majority of *Ae. aegypti* were targeted, meaning that resources could be deployed where they would have the greatest impact. Previous field trials demonstrated the utility of *Mesocylops* in reducing larval mosquito populations in large containers, wells, and even abandoned mineshafts, with much of the work conducted by, or in collaboration with, scientists from QIMR \[[@B61-tropicalmed-03-00071],[@B62-tropicalmed-03-00071],[@B63-tropicalmed-03-00071]\]. As part of the Vietnam program, local species of *Mesocyclops* were mass-reared, posted to target communities, and then inoculated into large water storage tanks that were prolific producers of *Ae. aegypti*. *Mesocyclops* and *Ae. aegypti* populations were routinely monitored post-inoculation using a variety of sampling methods \[[@B64-tropicalmed-03-00071],[@B65-tropicalmed-03-00071]\]. During a pilot field trial, *Ae. aegypti* was eliminated from Phanboi village, Haihung Province, northern Vietnam, a village of 400 houses \[[@B66-tropicalmed-03-00071]\]. Elimination only occurred when smaller containers that were not suitable for *Mesocyclops* treatment were removed as part of a community-wide recycling program. The program was expanded into a number of other provinces, leading to the elimination or suppression of *Ae. aegypti*, and a concomitant decrease in DENV infections \[[@B60-tropicalmed-03-00071],[@B67-tropicalmed-03-00071],[@B68-tropicalmed-03-00071]\]. Indications are that the program is sustainable at least seven years after the conclusion of formal control activities, and it appears to be a cost-effective strategy of controlling *Ae. aegypti* in Vietnam \[[@B69-tropicalmed-03-00071]\].

4.4. Utilizing Wolbachia for Dengue Control {#sec4dot4-tropicalmed-03-00071}
-------------------------------------------

A number of emerging technologies hold considerable promise for the sustained reduction in DENV transmission or elimination of *Ae. aegypi* populations (reviewed in \[[@B70-tropicalmed-03-00071]\]). In terms of progression to field releases, *Wolbachia*-based strategies are the most advanced of these technologies \[[@B71-tropicalmed-03-00071]\]. *Wolbachia* is an intracellular bacterium that occurs in over 60% of insect species \[[@B72-tropicalmed-03-00071]\]. High rates of maternal transmission, coupled with cytoplasmic incompatibility (CI), allow *Wolbachia* to rapidly drive into target insect populations. The process of CI gives infected insects a reproductive advantage, because crosses between uninfected females and infected males produce no offspring. However, crosses between infected females and uninfected or infected males produce viable offspring, allowing *Wolbachia* to perpetuate in the population.

*Wolbachia* naturally infects some medically important mosquito species, such as *Ae. albopictus* and *Cx. quinquefasciatus*. In contrast, *Ae. aegypti* is not naturally infected with *Wolbachia*; instead, the bacterium is transinfected from a natural host, such as *Drosophila melanogaster* or *Ae. albopictus*. Transinfection involves taking the bacterium from the natural host and microinjecting it into the eggs of *Ae. aegypti*. This was an extremely laborious process, which resulted in an exceedingly high level of mortality in the transinfected line. Using methods of Xi et al. and McMeniman et al. \[[@B73-tropicalmed-03-00071],[@B74-tropicalmed-03-00071]\], McMeniman et al. \[[@B75-tropicalmed-03-00071]\] was able to generate a line of *Ae. aegypti* stably infected with the *w*MelPop strain of *Wolbachia*. The *w*MelPop strain reduces the lifespan of *D. melanogaster*, and it was proposed that if this strain was successfully transinfected into *Ae. aegypti*, then it would reduce the lifespan of this species. A reduction in the lifespan would mean that fewer *Ae. aegypti* would survive for the length of the extrinsic incubation period, which is the time from when a virus is ingested by a mosquito in an infectious blood meal until it can be transmitted. Not only did *w*MelPop reduce the lifespan of transinfected mosquitoes in small cage trials \[[@B75-tropicalmed-03-00071]\], but it also conferred other phenotypes on *Ae. aegypti*, including altered blood-feeding behavior, and decreased fecundity and egg desiccation resistance \[[@B76-tropicalmed-03-00071],[@B77-tropicalmed-03-00071]\].

It was previously shown that *Wolbachia* afforded *D. melanogaster* protection from the infection with the highly pathogenic Drosophila C, cricket paralysis, and Flock House viruses \[[@B78-tropicalmed-03-00071]\]. Consequently, a number of experiments were undertaken at several laboratories in Brisbane, which revealed that DENV-2 and chikungunya virus replication and transmission were significantly inhibited by *Wolbachia* in transinfected *Ae. aegypti* \[[@B79-tropicalmed-03-00071]\]. So, rather than *Wolbachia* being used to change the age structure of *Ae. aegypti* populations, the focus shifted to releasing *Wolbachia*-infected mosquitoes to prevent these mosquitoes from transmitting DENVs \[[@B80-tropicalmed-03-00071]\]. However, the fitness costs associated with *w*MelPop meant that *Ae. aegypti* infected with this strain would struggle to survive post-release, especially during periods of low rainfall, such as the dry season in tropical locations \[[@B81-tropicalmed-03-00071]\]. Consequently, another strain of *Wolbachia* from *D. melanogaster*, *w*Mel, was transinfected into *Ae. aegypti*, where it displayed potent virus-inhibiting properties without the deleterious fitness costs on the host \[[@B82-tropicalmed-03-00071]\]. In purpose-built semi-field cages constructed near Cairns \[[@B83-tropicalmed-03-00071]\], *w*Mel rapidly invaded *Ae. aegypti* cohorts, and reached fixation as early as 30 days after weekly releases commenced \[[@B82-tropicalmed-03-00071]\].

Before proceeding to field deployment, extensive community engagement was undertaken and biosafety approval was obtained from the Australian Pesticides and Veterinary Medicines Authority. In early January 2011, weekly releases of *w*Mel-infected adult *Ae. aegypti* commenced in the north Queensland towns of Gordonvale and Yorkeys Knob \[[@B80-tropicalmed-03-00071]\]. Over 300,000 *w*Mel-infected mosquitoes were released during a 10-week period, resulting in 80%--90% infection frequency. Continual monitoring revealed that high *Wolbachia* frequency was maintained in the populations since this time \[[@B84-tropicalmed-03-00071]\]. Importantly, the virus-blocking phenotype was retained for at least one year post-release \[[@B85-tropicalmed-03-00071]\], and indications from Vietnam suggest longer-term stability \[[@B86-tropicalmed-03-00071]\]. Over the next six years, the World Mosquito Program (formerly Eliminate Dengue) conducted releases across a number of cities and towns in far north Queensland, including Cairns, Townsville, Charters Towers, Innisfail, and Port Douglas (<http://www.eliminatedengue.com/australia>, accessed on 30 May 2018). Similar releases were attempted with *w*MelPop-infected *Ae. aegypti* in north Queensland and Vietnam, but the associated fitness costs prevented the establishment of this *Wolbachia* strain in these populations \[[@B87-tropicalmed-03-00071]\]. Paradoxically, it was suggested that the lack of desiccation resistance in *w*MelPop-infected mosquito eggs could be exploited to eliminate focal populations of *Ae. aegypti* \[[@B88-tropicalmed-03-00071]\].

The success of releases in north Queensland led to the World Mosquito Program establishing deployment programs in 12 countries, including Brazil, Indonesia, Vietnam, and four countries of the southwestern Pacific region (<http://www.eliminatedengue.com/program>, accessed on 30 May 2018). Whilst it undoubtedly drives to near fixation in local *Ae. aegypti* populations, the success of *Wolbachia*-based interventions will be measured by a reduction in disease incidence attributed to DENV infection. Several different approaches are being used to evaluate the impact of *Wolbachia*, and include cluster randomized trials and observational studies, whereby the impact on dengue incidence is tracked through time (summarized in \[[@B89-tropicalmed-03-00071],[@B90-tropicalmed-03-00071]\]). The results of these epidemiological assessments will start becoming available over the next several years \[[@B91-tropicalmed-03-00071]\].

Like any biocontrol strategy, there are potential vulnerabilities in *Wolbachia*-based interventions \[[@B71-tropicalmed-03-00071]\]. Vulnerabilities that could impact effectiveness include the loss of or attenuation of *Wolbachia* infection in the mosquito, and the emergence of virus strains that are not only resistant to *Wolbachia*-mediated blocking, but which also increase virulence and disease pathogenesis in humans. Another issue that has been raised is the possible enhancement of the arbovirus infection in transinfected mosquitoes. This was based on a study that demonstrated that transient infection of *Cx. pipiens* with the *w*AlbB strain of *Wolbachia* resulted in an enhancement of a subsequent West Nile virus infection \[[@B92-tropicalmed-03-00071]\]. However, the authors acknowledged that their results may have differed if a stably-transinfected line of *Cx. pipiens* was used, instead of a transiently-infected line. Nonetheless, these potential vulnerabilities emphasize the complexity of *Wolbachia*--virus--mosquito interactions and the need for a thorough assessment of candidate strains to identify any risks before being considered for release. Importantly, ongoing monitoring of transinfected populations will be critical to ascertain any changes in *Wolbachia* prevalence and tissue density, whilst vector competence experiments will ensure the virus-blocking phenotype is being maintained \[[@B71-tropicalmed-03-00071]\]. To limit the impact of these confounding factors, *Ae. aegypti* infected with a different *Wolbachia* strain or superinfected with multiple strains could be deployed \[[@B93-tropicalmed-03-00071],[@B94-tropicalmed-03-00071]\].

5. Conclusions and Future Perspectives {#sec5-tropicalmed-03-00071}
======================================

Although there was some spectacular success in eliminating *Ae. aegypti*, most notably in South and Central America during the middle of the 20th century \[[@B95-tropicalmed-03-00071]\], the ever-increasing global burden of DENVs indicates that elimination or larvicide treatment of containers, and indiscriminate application of adulticides are largely ineffective for sustained control of *Ae. aegypti*. Anthropogenic factors, including unchecked urbanization and lack of associated infrastructure, proliferation of containers that support larval development, and poorly-resourced public health systems, further compromised the efficacy of these control strategies. Indeed, the increase in frequency of dengue outbreaks in north Queensland since the late 1990s necessitated that control strategies moved to a model that integrated patient contact tracing, TIRS, and larval control. Whilst these strategies undoubtedly limited the scale of DENV outbreaks in Australia \[[@B54-tropicalmed-03-00071],[@B58-tropicalmed-03-00071]\], they are resource-intensive, expensive, and can occasionally be overwhelmed, such as during the 2008--2009 Cairns DENV-3 outbreak.

The widespread deployment of *Wolbachia* since 2011 altered the dynamics of the relationship between *Ae. aegypti* and DENVs in north Queensland. Should the *Wolbachia* approach be as effective as modeling predicts in reducing transmission \[[@B89-tropicalmed-03-00071]\], then limitations of current control practices may not be as pronounced. Although there were fewer notified locally-acquired cases of dengue in the most recent years when compared with preceding years \[[@B96-tropicalmed-03-00071]\], the historical number of locally acquired cases in north Queensland is insufficient to statistically demonstrate a causative effect of *Wolbachia* on reduced local DENV transmission. Instead, the epidemiological studies currently underway in hyperendemic locations should provide the crucial data on the impact of *Wolbachia* on dengue incidence in a field setting. In response to the widespread deployment of *Wolbachia* in north Queensland, health authorities are integrating *Wolbachia* monitoring in *Ae. aegypti* populations into routine surveillance and control operations. For the foreseeable future, all suspected dengue cases will continue to be investigated, and the capacity to conduct intensive vector control activities based on TIRS and larval control will be maintained.

Unfortunately, *Ae. aegypti* is an adversary that continues to defy all efforts of controlling it. In the future, an integrated approach to surveillance and control, including source reduction, targeted insecticide application, and continued judicious deployment and monitoring of *Wolbachia* will have the greatest impact on mosquito populations and the associated the burden of DENVs. However, there are numerous issues that will need to be addressed as novel surveillance and control strategies are rolled out across highly urbanized regions where DENVs exact their greatest toll. The most important of these are their scalability and sustainability, as well as their impact on dengue incidence. Regardless, the considerable contribution that they made since Bancroft first incriminated *Ae. aegypti* as a vector of DENVs suggest that Australian scientists will be at the forefront of the development and adoption of these strategies.
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